Bruce A. Schmidt
Director/Board Member at VANCORD CAPITAL INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert de Wit | M | - |
WUTIF Capital (VCC), Inc.
 WUTIF Capital (VCC), Inc. Investment ManagersFinance WUTIF Capital (VCC), Inc seeks investment opportunities in companies located in the British Columbia. The fund targets companies operating in the fields of communications and information technology, health and life sciences technologies, physical sciences, energy and fuel cells sectors. It provides financing for seed and early stage capital requirements with an investment size of USD 0.025 - 0.25 million and also co-invests with others. | 7 years |
| Michael Volker | M | 76 |
WUTIF Capital (VCC), Inc.
WUTIF Capital (VCC), Inc. Investment ManagersFinance WUTIF Capital (VCC), Inc seeks investment opportunities in companies located in the British Columbia. The fund targets companies operating in the fields of communications and information technology, health and life sciences technologies, physical sciences, energy and fuel cells sectors. It provides financing for seed and early stage capital requirements with an investment size of USD 0.025 - 0.25 million and also co-invests with others.
WUTIF Management Corp.
 WUTIF Management Corp. Investment ManagersFinance WUTIF Management Corp (WUTIF) is an independent venture capital firm founded in 2003. The firm is headquartered in Canada. | 21 years |
| Robert I. Attwell | M | - |
myBestHelper Solution, Inc.
 myBestHelper Solution, Inc. Internet Software/ServicesTechnology Services myBestHelper Solution, Inc. owns and operates an online platform to connect families and helpers in Canada. It enables families to find and manage babysitters, nannies, and housecleaners, as well as helpers for home, child, and elder care. The company was founded in 2011 by Alexandra T. Greenhill and Rob Attwell and is headquartered in Vancouver, Canada. | 13 years |
| Alexandra Greenhill | M | - |
myBestHelper Solution, Inc.
myBestHelper Solution, Inc. Internet Software/ServicesTechnology Services myBestHelper Solution, Inc. owns and operates an online platform to connect families and helpers in Canada. It enables families to find and manage babysitters, nannies, and housecleaners, as well as helpers for home, child, and elder care. The company was founded in 2011 by Alexandra T. Greenhill and Rob Attwell and is headquartered in Vancouver, Canada. | 13 years |
| Richard Genovese | M | 69 | 15 years | |
| Tim David Collings | M | - |
WUTIF Management Corp.
WUTIF Management Corp. Investment ManagersFinance WUTIF Management Corp (WUTIF) is an independent venture capital firm founded in 2003. The firm is headquartered in Canada. | 21 years |
| Frank D. Anderson | M | 64 | 15 years | |
| Kirk Hamilton | M | - |
WUTIF Management Corp.
WUTIF Management Corp. Investment ManagersFinance WUTIF Management Corp (WUTIF) is an independent venture capital firm founded in 2003. The firm is headquartered in Canada. | 5 years |
| Gordon D. Skene | M | - |
WUTIF Management Corp.
WUTIF Management Corp. Investment ManagersFinance WUTIF Management Corp (WUTIF) is an independent venture capital firm founded in 2003. The firm is headquartered in Canada. | 21 years |
| Gregory J. Sprung | M | - |
BC Mental Health Foundation
| - |
| Aaron Stuart | M | - |
WUTIF Management Corp.
WUTIF Management Corp. Investment ManagersFinance WUTIF Management Corp (WUTIF) is an independent venture capital firm founded in 2003. The firm is headquartered in Canada. | 7 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Rosner | M | 59 | - | |
| David Alley | M | - | 1 years | |
| Janis D. Douville | F | - |
Medusa Style Corp.
| 5 years |
| Rosemonde Mandeville | M | - |
Biophage Pharma, Inc.
 Biophage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Biophage Pharma, Inc. is a biotechnology company. It develops phage-based products and technologies for the detection, prevention and control of bacterial infections. It operates through two divisions: Therapeutic and Biosensors. The Therapeutic division is engaged in the management of bacterial contaminations in the medical, veterinary and environmental. The Biosensors division is to the development and commercialization of novel biosensors. Biophage Pharma was founded in 1995 and is headquartered in Montreal, Canada. | - |
| Terrance Owen | M | 77 |
University of British Columbia
| 17 years |
| Ossama R. Hassanein | M | - |
University of British Columbia
| 4 years |
| James DeMesa | M | 66 |
MIGENIX, Inc.
 MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | 7 years |
| Ronald J. Zokol | M | 74 |
University of British Columbia
| 14 years |
| Chester Shynkaryk | M | 79 | 3 years | |
| Yung Tan Chen | M | 62 | 12 years | |
| John William Greenslade | M | 75 |
University of British Columbia
| 9 years |
| Pieter Dorsman | M | - |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | 2 years |
| Andrew J. Rae | M | - |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | 2 years |
| Doug Johnson | M | - |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | 2 years |
| James David Pratt | M | - | 7 years | |
| Alistair Duncan | M | - |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | 6 years |
| James Robertson | M | - |
University of British Columbia
| 6 years |
| David de Witt | M | 71 |
University of British Columbia
| 7 years |
| Paul Brennan | M | - |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | 1 years |
| AnnKatrin Petersen-Jappelli | M | - |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | 4 years |
| Douglas Eacrett | M | 78 |
University of British Columbia
| 6 years |
| David Nairne | M | - |
University of British Columbia
| 5 years |
| Allan H. Shapiro | M | - | - | |
| Michael Edward O'Connor | M | - |
University of British Columbia
| 4 years |
| Gordon William Blankstein | M | 73 |
University of British Columbia
| 7 years |
| Eugene Hodgson | M | 67 | 7 years | |
| Glenn Yeadon | M | 73 |
University of British Columbia
| 5 years |
| David Schwartz | M | - |
University of British Columbia
| 5 years |
| Jack H. L. Miller | M | - |
University of British Columbia
| 6 years |
| Donald Gordon | M | 68 | 3 years | |
| John W. Commissiong | M | 79 |
PNO Resources Ltd.
 PNO Resources Ltd. Other Metals/MineralsNon-Energy Minerals PNO Resources Ltd. engages in the acquisition and exploration of natural resource properties. The company was founded on February 22, 1983 and is headquartered in Vancouver, Canada. | - |
| Gordon Ellis | M | 77 |
University of British Columbia
| 6 years |
| John H. Caton | M | - | - | |
| Ryan Schmidt | M | - | - | |
| Ronald Tysoe | M | 71 |
University of British Columbia
| 5 years |
| P. Reifel | M | 72 |
University of British Columbia
| 6 years |
| James Dean | M | - | - | |
| Ted Cohen | M | 74 | - | |
| Leanne Bate | F | - |
PNO Resources Ltd.
PNO Resources Ltd. Other Metals/MineralsNon-Energy Minerals PNO Resources Ltd. engages in the acquisition and exploration of natural resource properties. The company was founded on February 22, 1983 and is headquartered in Vancouver, Canada. | 7 years |
| Thomas Beattie | M | - |
University of British Columbia
| 5 years |
| Linda J. Allison | M | 76 | 9 years | |
| David A. Yeager | M | - |
University of British Columbia
| 4 years |
| Mark Ralston | M | 71 |
University of British Columbia
| 4 years |
| Dae-Ryun Jang | M | 67 |
University of British Columbia
| 4 years |
| Karen L. Danielson | F | - |
University of British Columbia
| 4 years |
| Robin Hutchison | M | 68 |
University of British Columbia
| 4 years |
| David L. Adderley | M | 68 |
University of British Columbia
| 4 years |
| Georgios Polyhronopoulos | M | 66 |
University of British Columbia
| 4 years |
| Ron Anderson | M | - |
University of British Columbia
| 4 years |
| Howie Young | M | - |
University of British Columbia
| 4 years |
| Gordon R. Osinchuk | M | - |
University of British Columbia
| 4 years |
| John E. Boddie | M | 72 |
University of British Columbia
| 4 years |
| Murray L. Swales | M | 73 |
University of British Columbia
| 4 years |
| Richard E. Fortescue | M | 70 |
University of British Columbia
| 4 years |
| David Christie | M | 77 |
University of British Columbia
| 4 years |
| Douglas Buchanan | M | - |
University of British Columbia
| 4 years |
| Richard P. Schutte | M | - |
University of British Columbia
| 4 years |
| Ferdinand Lobkowicz | M | - |
University of British Columbia
| 4 years |
| Gary Moore | M | - |
University of British Columbia
| 4 years |
| Teh Ming Kwauk | M | 71 |
University of British Columbia
| 24 years |
| Ronald Ewing | M | - |
University of British Columbia
| 4 years |
| Glen MacDonald | M | 75 |
University of British Columbia
| 4 years |
| Donald Gee | M | 73 |
University of British Columbia
| 4 years |
| Christopher F. Yee | M | 66 |
University of British Columbia
| 4 years |
| Ross Beaty | M | 72 |
University of British Columbia
| 4 years |
| Yvan Joseph Bourdeau | M | - |
University of British Columbia
| 2 years |
| Dave Jiles | M | - |
University of British Columbia
| 4 years |
| Arthur James Mcfaull | M | - |
University of British Columbia
| 4 years |
| Carl G. Verley | M | - |
University of British Columbia
| 4 years |
| Ian Power | M | - |
University of British Columbia
| 4 years |
| Robert George Lewis | M | - |
University of British Columbia
| 3 years |
| Guy Gordon | M | - |
University of British Columbia
| 4 years |
| Hon Cheung So | M | 68 |
University of British Columbia
| 4 years |
| Wan H. Jung | M | 67 |
University of British Columbia
| 4 years |
| Bob Bebluk | M | - |
University of British Columbia
| 6 years |
| Martin John Gardner Glynn | M | 72 |
University of British Columbia
| 2 years |
| Deborah E. Fortescue-Merrin | F | 68 |
University of British Columbia
| 4 years |
| John Blanchflower | M | - |
University of British Columbia
| 4 years |
| Beverley Briscoe | F | 69 |
University of British Columbia
| 4 years |
| Neville Desmond Smith | M | 71 |
University of British Columbia
| 4 years |
| Peter M. Holbek | M | - |
University of British Columbia
| 6 years |
| J. Peter Campbell | M | - |
University of British Columbia
| 4 years |
| Andre J. Audet | M | - |
University of British Columbia
| 4 years |
| David Lyall | M | 68 |
University of British Columbia
| 4 years |
| Lorne Babiuk | M | - |
University of British Columbia
| 3 years |
| James Albert Turner | M | 75 |
University of British Columbia
| 4 years |
| Lam Sin Lai Tsui | M | 69 |
University of British Columbia
| 4 years |
| Terry Krepiakevich | M | 71 |
University of British Columbia
| 4 years |
| Lee Herbert | M | 71 |
University of British Columbia
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 94 | 94.00% |
| United States | 6 | 6.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Bruce A. Schmidt
- Personal Network
